Skip to main content
OpenTrials
Completed

NCT Number: NCT00186368

Microarray Analysis of Gene Expression in Prostate Tissues

The purpose of this study is to investigate gene expression profiles and biologic features of prostate tissue and how they relate to prostate cancer development and growth.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

Male

Study type

Observational

Primary location

Stanford University Cancer Center

Stanford, California, 94305, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patient scheduled to undergo either a biopsy or surgery for a prostate condition.

Exclusion criteria

  • Patients without a prostate condition

Treatment and study plan

Primary outcomes

  1. Correlate genotype with pathologic phenotype and clinical outcome.

    Time frame: one time

    The Tissue Bank will store all "Tissue Bank" consents. The patients will be given a unique identifier by the tissue bank. However, patients will need to be identified to link to clinical data and possible followup (if they have consented) via chart or tumor registries.

Sponsors and collaborators

Lead sponsor

Stanford University

Other

Collaborators

  • National Cancer Institute (NCI)
  • National Institutes of Health (NIH)
  • University of Wisconsin, Madison

Registry information

Official study title

Microarray Analysis of Gene Expression in Prostate Tissues (Translating Prostate Cancer Gene Expression Sub-types)

Important dates

Study start
1999
Primary completion
2009
Study completion
2009
First posted
Sep 16, 2005
Registry last updated
Jan 12, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.